Company / Shareholders' Equity
Penumbra, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.4B
FY2025
5-year range
$637.8M / $1.4B
FY2021-FY2025
Trend
+24.0%
vs FY2024
Sector context
#70 of 161
Health Care
What the data says
At $1.4B, Penumbra, Inc.'s shareholders' equity ranks #70 of 161 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $267M in FY2016 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +17.3%.
Improved from $1.2B to $1.4B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +30.8%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
#70 of 161 in Health CareTop 43% of 161This company $1.4B Sector average $5.1B
▼
-71.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2025, shareholders' equity increased 24.0% year-over-year.
- Ranks #70 out of 161 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +24.0% |
| FY2024 | $1.2B | -2.4% |
| FY2023 | $1.2B | +84.8% |
| FY2022 | $637.8M | -33.1% |
| FY2021 | $953.9M | +48.7% |
| FY2020 | $641.5M | +32.0% |
| FY2019 | $485.9M | +15.1% |
| FY2018 | $422.2M | +5.5% |
| FY2017 | $400.4M | +50.2% |
| FY2016 | $266.5M | +14.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026